ALTAMIRA THERAPEUTICS LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.6 USD | +11.11% |
|
+13.15% | -54.02% |
Chart calendar Altamira Therapeutics Ltd.
aa73b04c5c817127.T4d_4__zKBCNiuBpbz8YCjk4namREJbyEuomUsQulGc.JOM-qLOLXHy0yKImXmwqc3ByyOjwQ8HFQYN0I4F3oAsi5S26usFYY8v6pQ~1905450ccba49b4a627569b05cd85ad0
Upcoming events on Altamira Therapeutics Ltd.
Past events on Altamira Therapeutics Ltd.
| 2024-04-10 08:30 am | Q4 2023 Earnings Call |
| 2024-04-10 08:00 am | Q4 2023 Earnings Release |
| 2024-01-22 | MRNA Based Therapeutics Summit |
| 2023-12-11 08:30 am | Business Update Call |
| 2023-09-12 08:00 am | Q2 2023 Earnings Call |
| 2023-09-12 07:30 am | Q2 2023 Earnings Release |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-03-20 | RNAi Based Therapeutics Summit |
| 2023-02-25 10:45 am | American Academy of Allergy, Asthma & Immunology Meeting |
| 2023-02-17 07:30 am | Extraordinary Shareholders Meeting |
| 2023-02-07 | RNA Therapeutics Conference |
| 2023-01-23 | mRNA-Based Therapeutics Summit Europe Conference |
| 2022-11-30 08:47 am | Interim 2022 Earnings Release |
| 2022-11-15 | TIDES Europe Event |
| 2022-10-17 | RNA Leaders USA Congress |
| 2022-09-25 | RAS-Targeted Drug Development Summit |
| 2022-09-14 10:30 am | Business Update Call |
| 2022-05-24 07:00 am | H.C. Wainwright Global Life Sciences Investment Conference |
| 2022-04-12 08:00 am | FY 2021 Earnings Call |
| 2022-04-12 07:30 am | FY 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2024 |
|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 0,00 0,00 - | 0,00 |
|
EBITDA Million CHF | Released Forecast Spread | -7,23 -11,0 33.99% | 0,00 |
|
EBIT Million CHF | Released Forecast Spread | -7,26 -10,6 31.76% | -7 846 208 |
|
Earnings before Tax (EBT) Million CHF | Released Forecast Spread | -6,83 -10,7 36.24% | 0,00 |
|
Net income Million CHF | Released Forecast Spread | -6,63 -9,31 28.74% | 0,00 |
|
EPS CHF | Released Forecast Spread | -912 -1 338 31.84% | 0,00 |
| Announcement Date | 16/04/20 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
|---|---|---|---|---|---|---|
|
Net sales Million CHF | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 0,00 | |
|
EBIT Million CHF | Released Forecast Spread | -3,15 -5,23 39.68% | ||||
|
Net income Million CHF | Released Forecast Spread | -3,03 -4,83 37.25% | ||||
|
EPS CHF | Released Forecast Spread | -248 -588 57.82% | ||||
| Announcement Date | 16/04/20 | - | - | - | - |
More events
Past sector events for Altamira Therapeutics Ltd.
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- CYTO Stock
- Calendar Altamira Therapeutics Ltd.
